Soligenix
SNGX
#10213
Rank
โ‚น1.09 B
Marketcap
โ‚น108.31
Share price
-1.26%
Change (1 day)
-44.96%
Change (1 year)

Revenue for Soligenix (SNGX)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of โ‚น10.03 Million a decrease over the revenue in the year 2023 that were of โ‚น21.4 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Soligenix from 1998 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A-100%
2024 โ‚น10.03 M-53.11%
2023 โ‚น21.4 M3.49%
2022 โ‚น20.68 M733.38%
2021 โ‚น2.48 M-98.24%
2020 โ‚น0.14 B-38.43%
2019 โ‚น0.22 B-17.3%
2018 โ‚น0.27 B0.47%
2017 โ‚น0.27 B-61.13%
2016 โ‚น0.71 B21.85%
2015 โ‚น0.58 B30.54%
2014 โ‚น0.44 B124.1%
2013 โ‚น0.19 B15.69%
2012 โ‚น0.17 B-57.53%
2011 โ‚น0.40 B364.48%
2010 โ‚น87.27 M-33.21%
2009 โ‚น0.13 B17.67%
2008 โ‚น0.11 B124.85%
2007 โ‚น49.38 M-51.79%
2006 โ‚น0.10 B-23.5%
2005 โ‚น0.13 B
1999 โ‚น0 M-100%
1998 โ‚น17 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚น8.494 TN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น5.787 TN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น4.380 TN/A๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
โ‚น20.83 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
โ‚น7.37 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น1.590 TN/A๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
โ‚น58.24 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น69.19 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA